Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

The beta cells of the pancreas don’t need the assistance of other pancreatic cells to produce insulin, according to new research. The findings are not only a potential game-changer for diabetics, but ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

Also known as juvenile-onset or insulin-dependent diabetes, this type of diabetes is not related to lifestyle and may occur ...

A new consensus statement summarizes the benefits, limitations, and challenges of using automated insulin delivery (AID) systems and provides recommendations for use by people with diabetes.

The bionic pancreas uses algorithms to continually adjust insulin doses based on the user’s needs, requiring less user input compared with other existing artificial pancreas technologies. A bionic ...

DEAR MAYO CLINIC: My wife is 31 and was diagnosed with type 1 diabetes at age 7. She had a baby three months ago, and her blood sugar levels were never really controlled. Doctors tested her kidney ...

GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today announced that the first participant has been dosed in ...

Add Yahoo as a preferred source to see more of our stories on Google. Unsung delta cells—long thought to play only a supporting role—are actually key players in protecting you from dangerous drops in ...

The US Food and Drug Administration (FDA) has cleared Beta Bionics's iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and older with type 1 diabetes. Working together with a ...